These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37373067)

  • 1. Prohibitin Links Cell Cycle, Motility and Invasion in Prostate Cancer Cells.
    Koushyar S; Uysal-Onganer P; Jiang WG; Dart DA
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours.
    Dart DA; Spencer-Dene B; Gamble SC; Waxman J; Bevan CL
    Endocr Relat Cancer; 2009 Dec; 16(4):1157-69. PubMed ID: 19635783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cells.
    Koushyar S; Economides G; Zaat S; Jiang W; Bevan CL; Dart DA
    Oncogenesis; 2017 May; 6(5):e333. PubMed ID: 28504694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase.
    Yu P; Duan X; Cheng Y; Liu C; Chen Y; Liu W; Yin B; Wang X; Tao Z
    Int J Mol Med; 2017 Nov; 40(5):1426-1434. PubMed ID: 28901378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens.
    Dart DA; Brooke GN; Sita-Lumsden A; Waxman J; Bevan CL
    Oncogene; 2012 Oct; 31(43):4588-98. PubMed ID: 22179832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural protein gamma-synuclein interacting with androgen receptor promotes human prostate cancer progression.
    Chen J; Jiao L; Xu C; Yu Y; Zhang Z; Chang Z; Deng Z; Sun Y
    BMC Cancer; 2012 Dec; 12():593. PubMed ID: 23231703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
    Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
    J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prohibitin, a protein downregulated by androgens, represses androgen receptor activity.
    Gamble SC; Chotai D; Odontiadis M; Dart DA; Brooke GN; Powell SM; Reebye V; Varela-Carver A; Kawano Y; Waxman J; Bevan CL
    Oncogene; 2007 Mar; 26(12):1757-68. PubMed ID: 16964284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CA916798 affects growth and metastasis of androgen-dependent prostate cancer cells.
    He J; Lan X; Duan HL; Luo H; Zhou XD
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4477-4487. PubMed ID: 30058677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells.
    Lin HP; Lin CY; Hsiao PH; Wang HD; Jiang SS; Hsu JM; Jim WT; Chen M; Kung HJ; Chuu CP
    PLoS One; 2013; 8(12):e82625. PubMed ID: 24349321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer.
    Takayama K; Horie-Inoue K; Suzuki T; Urano T; Ikeda K; Fujimura T; Takahashi S; Homma Y; Ouchi Y; Inoue S
    Mol Endocrinol; 2012 May; 26(5):748-61. PubMed ID: 22456197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells.
    Won SH; Lee HJ; Jeong SJ; Lü J; Kim SH
    Phytother Res; 2012 May; 26(5):669-74. PubMed ID: 21997969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor.
    Qu F; Cui X; Hong Y; Wang J; Li Y; Chen L; Liu Y; Gao Y; Xu D; Wang Q
    Mol Cell Biochem; 2013 May; 377(1-2):121-30. PubMed ID: 23417242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity.
    Chen C; Shao R; Li B; Zhai Y; Wang T; Li X; Miao L; Huang J; Liu R; Liu E; Zhu Y; Gao X; Zhang H; Wang Y
    Phytomedicine; 2021 May; 85():153514. PubMed ID: 33676083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
    Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T
    Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.
    Dai JL; Maiorino CA; Gkonos PJ; Burnstein KL
    Steroids; 1996 Sep; 61(9):531-9. PubMed ID: 8883219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prohibitin promotes androgen receptor activation in ER-positive breast cancer.
    Liu P; Xu Y; Zhang W; Li Y; Tang L; Chen W; Xu J; Sun Q; Guan X
    Cell Cycle; 2017 Apr; 16(8):776-784. PubMed ID: 28272969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of lysine-specific demethylase 1 promotes androgen-independent transition of human prostate cancer LNCaP cells through activation of the AR signaling pathway and suppression of the p53 signaling pathway.
    Li X; Li T; Chen D; Zhang P; Song Y; Zhu H; Xiao Y; Xing Y
    Oncol Rep; 2016 Jan; 35(1):584-92. PubMed ID: 26534764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells.
    Hååg P; Bektic J; Bartsch G; Klocker H; Eder IE
    J Steroid Biochem Mol Biol; 2005 Aug; 96(3-4):251-8. PubMed ID: 15982869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.